Close Menu

NEW YORK (360Dx) – Singapore cancer diagnostics firm Clearbridge BioMedics said today that it has secured S$6.6 million ($4.8 million) in funding ahead of a planned initial public offering.

According to the company, the round drew interest from both biotech investors, and from medical professionals in the oncology space. Money raised will support Clearbridge's business expansion, technology development, talent recruitment, and expenses related to its potential listing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.